Reference priceJPY ¥1,105.93Original source price: INR 631.96. Converted estimates are available by currency selection.
| Brand | Nihon Pharmaceutical Co.Ltd |
|---|---|
| Manufacturer | Nihon Pharmaceutical Co.Ltd. |
| Prescription required | Yes |
Capecitabine Tablets 56 x 300mg(NK)
Capecitabine
Description
Capecitabine Tablets 56 x 300mg(NK) is a medicine catalog record in the MediPriceHub database. Active ingredient: Capecitabine. Clinical use summary: See the Benefits field on this page for the product-specific indication or intended use. That field is kept separate from catalog metadata so users can distinguish clinical information from packaging information. Manufacturer or supplier: Nihon Pharmaceutical Co.Ltd.. Therapeutic category: Medicine Library > Oncology Medicines > Gastric Cancer Medicines (Gastric Adenocarcinoma and Gastroesophageal Cancer). Pack information: 300 / 56. Origin country or market: Japan. This page is for medicine catalog reference only and should be read together with the approved prescribing information in the patient or buyer's country.Benefits
XELODA (capecitabine) is a nucleoside metabolic inhibitor indicated for: Colorectal Cancer Breast Cancer Gastric, Esophageal, or Gastroesophageal Junction Cancer Pancreatic Cancer adjuvant treatment of patients with Stage III colon cancer as a single agent or as a component of a combination chemotherapy regimen. perioperative treatment of adults with locally advanced rectal cancer as a component of chemoradiotherapy. treatment of patients with unresectable or metastatic colorectal cancer as a single agent or as a component of a combination chemotherapy regimen. treatment of patients with advanced or metastatic breast cancer as a single agent if an anthracycline- or taxane-containing chemotherapy is not indicated. treatment of patients with advanced or metastatic breast cancer in combination with docetaxel after disease progression on prior anthracycline-containing chemotherapy. treatment of adults with unresectable or metastatic gastric, esophageal, or gastroesophageal junction cancer as a component of a combination chemotherapy regimen. treatment of adults with HER2-overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease as a component of a combination regimen. adjuvant treatment of adults with pancreatic adenocarcinoma as a component of a combination chemotherapy regimen.How to Use
Use Capecitabine under the supervision of a qualified healthcare professional. Take it by mouth only according to the approved label and the dose prescribed by a qualified healthcare professional. Do not start, stop, change the dose, split or crush a dosage form, mix with other medicines, or repeat a course unless the approved product information or a clinician confirms that it is appropriate. Check the local prescribing information for age limits, dose adjustments, missed-dose instructions, storage after opening or reconstitution, and monitoring requirements.Specification
Active ingredient: Capecitabine. Pack size: 300 / 56. Pack unit: box. Manufacturer: Nihon Pharmaceutical Co.Ltd.. Origin country: Japan. Source category: Medicine Library > Oncology Medicines > Gastric Cancer Medicines (Gastric Adenocarcinoma and Gastroesophageal Cancer). Availability, prescription status, storage, and exact approved use may vary by country. Check the local product information before clinical or procurement decisions.Side Effects
Cancer medicines may cause fatigue, nausea, vomiting, diarrhea or constipation, appetite changes, mouth sores, rash, changes in blood counts, infection risk, liver or kidney test changes, bleeding risk, neuropathy, infusion reactions, or organ-specific toxicity depending on the medicine. Seek urgent medical care for severe allergic symptoms, breathing difficulty, fainting, severe skin reactions, chest pain, confusion, serious bleeding, signs of infection, or rapidly worsening symptoms. The approved local prescribing information is the controlling source for the complete adverse-reaction profile.この情報は参考情報です。医薬品を使用する前に医療専門家へご相談ください。